Early Prevention of Obesity: Tackling from Conception

By Melike Belenli Gümüş

October 16, 2024

A recent article discusses the potential for monitoring obesity from the earliest stages of development, including during the fetal period in the womb. This proactive approach highlights the importance of addressing obesity right from conception in order to achieve early prevention of obesity.

Early Prevention of Obesity

The article highlights research focused on the early prevention of obesity through a project named “eprObes” (Early Prevention of Obesity). This initiative aims to implement interventions that could significantly lower the risk of obesity later in life.

Factors Influencing Obesity

The study aims to identify and understand the various factors that contribute to obesity, starting from the pre-conception period and continuing through pregnancy and early childhood. These factors include genetic, environmental, and lifestyle influences that can affect the development of obesity in children.

Importance of Prenatal Care

The research emphasises the critical role of prenatal care in monitoring both the mother’s and the fetus’s health. Preventive measures during pregnancy could be key in reducing the incidence of obesity later in life.

Long-Term Health Implications

By addressing obesity at its earliest roots, the study aims to lower the risk of long-term health complications associated with obesity, such as metabolic syndrome, diabetes, and other related health issues.

Overall, the article indicates a shift towards a more proactive and preventive approach to managing obesity, starting at the earliest possible stage of human development. This new focus could lead to healthier outcomes for future generations.

Reference url

Recent Posts

Unlocking the Benefits of Cardiovascular Health Checks in EU Prevention Strategies

By HEOR Staff Writer

May 7, 2026

Cardiovascular health checks deliver strong clinical, economic and societal value when delivered as structured, risk-based programmes connected to ongoing care. This approach supports EU cardiovascular prevention strategies by catching cardiometabolic risks early and reducing long-term events. Th...
Rui Santos Ivo Advocates for Regulatory Frameworks Innovation at RAPS Euro Convergence 2026
Rui Santos Ivo, President of the INFARMED Board of Directors and Chair of the European Medicines Agency (EMA) Management Board, emphasized the need for regulatory frameworks innovation during the opening session of the Regulatory Affairs Professionals Society (RAPS) Euro Convergence 2026 conferen...
MFN Drug Pricing Savings: Projected $593 Billion in U.S. Healthcare Savings Over Ten Years
The MFN drug pricing savings under the Trump Administration’s voluntary framework total hundreds of billions of dollars. The policy has already secured agreements with 17 manufacturers and is projected to deliver $529 billion in U.S. savings over ten years from new drugs, plus an additional $64.3...